Role of clinical history in beta-lactam hypersensitivity.
Journal
Current opinion in allergy and clinical immunology
ISSN: 1473-6322
Titre abrégé: Curr Opin Allergy Clin Immunol
Pays: United States
ID NLM: 100936359
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
pubmed:
1
6
2021
medline:
15
12
2021
entrez:
31
5
2021
Statut:
ppublish
Résumé
Understand how the clinical history has been used to risk stratify patients reporting a beta-lactam allergy, both in clinical care pathways and predictive models. Drug allergy clinical care pathways have emerged as a safe and effective method of stratifying patients with a reported beta-lactam allergy into risk categories, with 'low-risk' patients able to proceed straight to direct challenges or test doses. These methods have streamlined antibiotic stewardship policies and penicillin allergy de-labeling. However, how to define 'low-risk' has been subject to much debate. New research has developed predictive models that utilize the clinical history to assess a patient's true risk of beta-lactam allergy. The clinical history has long been an essential part of drug allergy evaluation and has proven invaluable within the past decade in the development of drug allergy clinical pathways. Evidence-based predictive models that use the clinical history to assess a patient's true risk of beta-lactam allergy offer tremendous promise, but differ in crucial areas such as the populations they study, the predictor variables they use, and the ultimate accuracy they attain. These models highlight key aspects of the drug allergy history and pave the way for future large-scale research.
Identifiants
pubmed: 34054028
doi: 10.1097/ACI.0000000000000758
pii: 00130832-202108000-00003
pmc: PMC8243834
mid: NIHMS1705916
doi:
Substances chimiques
Anti-Bacterial Agents
0
Penicillins
0
beta-Lactams
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
320-326Subventions
Organisme : NIAID NIH HHS
ID : K01 AI125631
Pays : United States
Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Abrams EM, Wakeman A, Gerstner TV, Warrington RJ, Singer AG. Prevalence of beta-lactam allergy: a retrospective chart review of drug allergy assessment in a predominantly pediatric population. Allergy Asthma Clin Immunol 2016; 12:59doi:10.1186/s13223-016-0165-6.
doi: 10.1186/s13223-016-0165-6
van Dijk SM, Gardarsdottir H, Wassenberg MW, et al. The high impact of penicillin allergy registration in hospitalized patients. J Allergy Clin Immunol Pract 2016; 4:926–931.
Macy E. Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep 2014; 14:476doi:10.1007/s11882-014-0476-y.
doi: 10.1007/s11882-014-0476-y
Macy E, Roppe LB, Schatz M. Routine penicillin skin testing in hospitalized patients with a history of penicillin allergy. Perm J 2004; 8:20–24.
Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA 2017; 318:82–83.
Trubiano JA, Vogrin S, Chua KYL, et al. Development and validation of a penicillin allergy clinical decision Rule. JAMA Intern Med 2020; 180:745–752.
Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259–273.
Mirakian R, Leech SC, Krishna MT, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy 2015; 45:300–327.
Penicillin Allergy in Antibiotic Resistance Workgroup. Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. J Allergy Clin Immunol Pract 2017; 5:333–334.
Demoly P, Adkinson NF, Brockow K, et al. International Consensus on drug allergy. Allergy 2014; 69:420–437.
Stevenson B, Trevenen M, Klinken E, et al. Multicenter Australian Study to determine criteria for low- and high-risk penicillin testing in outpatients. J Allergy Clin Immunol Pract 2020; 8:681–689 e3.
Mill C, et al. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr 2016; 170:e160033.
Confino-Cohen R, Rosman Y, Meir-Shafrir K, et al. Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity. J Allergy Clin Immunol Pract 2017; 5:669–675.
Goldberg A, Confino-Cohen R. Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. Ann Allergy Asthma Immunol 2008; 100:37–43.
Iammatteo M, Alvarez Arango S, Ferastraoaru D, et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract 2019; 7:236–243.
Tucker MH, et al. Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits. J Allergy Clin Immunol Pract 2017; 5:813–815.
Ramsey A, Caubet JC, Blumenthal K. Risk stratification and prediction in beta-lactam allergic patients. J Allergy Clin Immunol Pract 2019; 7:2182–2184.
Banks TA, Tucker M, Macy E. Evaluating penicillin allergies without skin testing. Curr Allergy Asthma Rep 2019; 19:27doi:10.1007/s11882-019-0854-6.
doi: 10.1007/s11882-019-0854-6
Conway EL, Lin K, Sellick JA, et al. Impact of penicillin allergy on time to first dose of antimicrobial therapy and clinical outcomes. Clin Ther 2017; 39:2276–2283.
Macy E, Vyles D. Who needs penicillin allergy testing? Ann Allergy Asthma Immunol 2018; 121:523–529.
Blumenthal KG, Ryan EE, Li Y, et al. The Impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis 2018; 66:329–336.
McDanel JS, et al. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible staphylococcus aureus bloodstream infections among 122 hospitals. Clin Infect Dis 2015; 61:361–367.
Macy E, Shu Y-H. The effect of penicillin allergy testing on future healthcare utilization: a matched cohort study. J Allergy Clin Immunol Pract 2017; 5:705–710.
Blumenthal KG, Huebner EM, Fu X, et al. Risk-based pathway for outpatient penicillin allergy evaluations. J Allergy Clin Immunol Pract 2019; 7:2411–2414 e1.
Blanca M, Mayorga C, Torres MJ, et al. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 2001; 56:862–870.
Blumenthal KG, Park MA, Macy EM. Redesigning the allergy module of the electronic health record. Ann Allergy Asthma Immunol 2016; 117:126–131.
Sousa-Pinto B, Tarrio I, Blumenthal KG, et al. Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis. J Allergy Clin Immunol 2021; 147:296–308.
Knezevic B, Sprigg D, Seet J, et al. The revolving door: antibiotic allergy labelling in a tertiary care centre. Intern Med J 2016; 46:1276–1283.
Mill C, Primeau MN, Medoff E, et al. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr 2016; 170:e160033.
Mustafa SS, Conn K, Ramsey A. Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial. J Allergy Clin Immunol Pract 2019; 7:2163–2170.
Marshall GD. The status of US allergy/immunology physicians in the 21st century: a report from the American Academy of Allergy, Asthma & Immunology Workforce Committee. J Allergy Clin Immunol 2007; 119:802–807.
Blumenthal KG, Li Y, Banerji A, et al. The cost of penicillin allergy evaluation. J Allergy Clin Immunol Pract 2018; 6:1019–1027.e2.
Sousa-Pinto B, Blumenthal KG, Macy E, et al. Penicillin allergy testing is cost-saving: an economic evaluation study. Clin Infect Dis 2020; 72:924–938.
Shenoy ES, Macy E, Rowe T, et al. Evaluation and management of penicillin allergy: a review. JAMA 2019; 321:188–199.
Wolfson AR, Huebner EM, Blumenthal KG. Acute care beta-lactam allergy pathways: approaches and outcomes. Ann Allergy Asthma Immunol 2019; 123:16–34.
Blumenthal KG, Wickner PG, Hurwitz S, et al. Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship. J Allergy Clin Immunol 2017; 140:154–161.e6.
Blumenthal KG, Shenoy ES, Wolfson AR, et al. Addressing inpatient beta-lactam allergies: a multihospital implementation. J Allergy Clin Immunol Pract 2017; 5:616–625 e7.
Krishna MT, Huissoon AP, Li M, et al. Enhancing antibiotic stewardship by tackling “spurious” penicillin allergy. Clin Exp Allergy 2017; 47:1362–1373.
Chiriac AM, Banerji A, Gruchalla RS, et al. Controversies in drug allergy: drug allergy pathways. J Allergy Clin Immunol Pract 2019; 7:46–60 e4.
Alam M, Bastakoti B. Therapeutic guidelines: antibiotic. version 15. Australian Prescriber 2015; 38:137.
Chiriac AM, Wang Y, Schrijvers R, et al. Designing predictive models for beta-lactam allergy using the drug allergy and hypersensitivity database. J Allergy Clin Immunol Pract 2018; 6:139–148.e2.
Siew LQC, Li PH, Watts TJ, et al. Identifying low-risk beta-lactam allergy patients in a UK Tertiary Centre. J Allergy Clin Immunol Pract 2019; 7:2173–2181 e1.
Moreno EM, Moreno V, Laffond E, et al. Usefulness of an Artificial Neural Network in the Prediction of beta-Lactam Allergy. J Allergy Clin Immunol Pract 2020; doi:10.1016/j.jaip.2020.07.010.
doi: 10.1016/j.jaip.2020.07.010
Blumenthal KG. The role of the clinical history in drug allergy prediction. J Allergy Clin Immunol Pract 2018; 6:149–150.